Cargando…
Autoinflammatory Reaction in Dogs Treated for Cancer via G6PD Inhibition
Glucose-6-phosphate dehydrogenase (G6PD) is an oncoprotein that is overexpressed in cancer cells to provide the NADPH required for their increased anabolism. NADPH, sourced from G6PD fuels nucleotide biosynthesis, maintains redox potential of thioredoxin and glutathione and drives the mevalonate pat...
Autor principal: | Nyce, Jonathan W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6005277/ https://www.ncbi.nlm.nih.gov/pubmed/29955429 http://dx.doi.org/10.1155/2017/4275305 |
Ejemplares similares
-
An autoinflammatory neurological disease due to interleukin 6 hypersecretion
por: Salsano, Ettore, et al.
Publicado: (2013) -
Interleukin-6 inhibition in the treatment of autoinflammatory diseases
por: Koga, Tomohiro, et al.
Publicado: (2022) -
Autoinflammatory gene mutations associated with eosinophilia and asthma
por: Alotaibi, Bashayr M., et al.
Publicado: (2023) -
G6PD deficiency and aluminum phosphide poisoning
por: Vosooghi, Ali Akbar, et al.
Publicado: (2018) -
Liver Failure in Neonates With G6PD Deficiency
por: Shah, Milaan, et al.
Publicado: (2022)